---
figid: PMC6122069__ijms-19-02411-g001
figtitle: Two major signaling axes in IGF-1-mediated EMTs in human breast, lung, and
  gastric cancers
organisms:
- NA
organisms_ner:
- Homo sapiens
pmcid: PMC6122069
filename: ijms-19-02411-g001.jpg
figlink: /pmc/articles/PMC6122069/figure/ijms-19-02411-f001/
number: F1
caption: 'Two major signaling axes in IGF-1-mediated EMTs in human breast, lung, and
  gastric cancers. IGF-1/IGF-1R signaling axis via IRS-1/PI3K/AKT/GSK-3β/NF-κB and
  RAS/RAF/MEK/ERK pathways leads to the activation of EMT markers, namely ZEB1/2,
  SNAIL1 and TWIST1. The interplay between IGF-1 and TGF-β signaling pathways for
  EMT induction is also indicated. The key mediators involved in EMT induction by
  IGF-1 are labeled with (#) in breast, (§) in lung cancers and (*) in gastric. WISP3:
  WNT1 inducible signaling pathway protein 3; TM4SF4: transmembrane 4L six family
  member 4; ANXA2: annexin A2; CBLB: Cbl proto-oncogene B; IFITM2: interferon induced
  transmembrane protein 2; STAT3: signal transducer and activator of transcription
  3; MUC1: mucin1; DDR1: discoidin domain receptor 1; MEMO1: mediator of ErbB2-driven
  cell motility 1; PTP: phosphotyrosine phosphatase; FAK: focal adhesion kinase.'
papertitle: Molecular Signatures of the Insulin-Like Growth Factor 1-Mediated Epithelial-Mesenchymal
  Transition in Breast, Lung and Gastric Cancers.
reftext: Armando Cevenini, et al. Int J Mol Sci. 2018 Aug;19(8):2411.
year: '2018'
doi: .na.character
journal_title: .na.character
journal_nlm_ta: .na.character
publisher_name: .na.character
keywords: .na.character
automl_pathway: 0.9550788
figid_alias: PMC6122069__F1
figtype: Figure
redirect_from: /figures/PMC6122069__F1
ndex: 1d5853e7-deeb-11ea-99da-0ac135e8bacf
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC6122069__ijms-19-02411-g001.html
  '@type': Dataset
  description: 'Two major signaling axes in IGF-1-mediated EMTs in human breast, lung,
    and gastric cancers. IGF-1/IGF-1R signaling axis via IRS-1/PI3K/AKT/GSK-3β/NF-κB
    and RAS/RAF/MEK/ERK pathways leads to the activation of EMT markers, namely ZEB1/2,
    SNAIL1 and TWIST1. The interplay between IGF-1 and TGF-β signaling pathways for
    EMT induction is also indicated. The key mediators involved in EMT induction by
    IGF-1 are labeled with (#) in breast, (§) in lung cancers and (*) in gastric.
    WISP3: WNT1 inducible signaling pathway protein 3; TM4SF4: transmembrane 4L six
    family member 4; ANXA2: annexin A2; CBLB: Cbl proto-oncogene B; IFITM2: interferon
    induced transmembrane protein 2; STAT3: signal transducer and activator of transcription
    3; MUC1: mucin1; DDR1: discoidin domain receptor 1; MEMO1: mediator of ErbB2-driven
    cell motility 1; PTP: phosphotyrosine phosphatase; FAK: focal adhesion kinase.'
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - CCN6
  - IGF1
  - IGF1R
  - TGFB1
  - TGFB2
  - TGFB3
  - TGFBR1
  - TGFBR2
  - TGFBR3
  - TM4SF4
  - DDR1
  - SRC
  - FGR
  - FYN
  - YES1
  - GPR162
  - ANXA2
  - PAX6
  - ELP4
  - PTK2
  - CBLB
  - MMAB
  - IRS1
  - MEMO1
  - LOC7795
  - SHC1
  - PIK3CA
  - PIK3CB
  - PIK3CD
  - PIK3CG
  - PIK3R3
  - PIK3R4
  - PIK3R5
  - PIK3R6
  - PIK3R1
  - PIK3R2
  - KRAS
  - HRAS
  - NRAS
  - MTOR
  - RPTOR
  - GRB2
  - IFITM2
  - MAPKAP1
  - RICTOR
  - MLST8
  - XYLT2
  - SOS1
  - SOS2
  - AKT1
  - AKT2
  - AKT3
  - ZHX2
  - ARAF
  - BRAF
  - RAF1
  - MUC1
  - MIR200C
  - NFKB1
  - CTNNB1
  - MAPK3
  - MAPK1
  - STAT3
  - TWIST1
  - ZEB1
  - ZEB2
  - SNAI1
  - ITK
  - SLC22A3
  - SLC25A3
  - REG1A
  - PTPRU
  - MAP2K1
  - MAP2K2
  - Breast cancer
  - SS Lung cancer
  - cancer
---
